U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse announces the availability of funding for implementation of the Prevention and Treatment of Substance Using Populations With or at Risk for Hepatitis C Virus (HCV) (R34) Planning Grant. The purpose of this grant is to conduct the initial development of a clinical trial or research project focused on prevention and treatment of HCV for at-risk substance using populations, including those infected with or at risk for HIV. The R34 supports the establishment of the research team; the development of tools for data . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | March 3, 2014

Federal Government Announces Prevention and Treatment of Substance Using Populations With or at Risk for HCV (R34) Planning Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member